Author: E.N. Gopchuk, Women’s consultation of the Pechersk District Regional Residential Assistance Center, Kyiv
Vulvovaginal candidiasis is a deep medical and social problem, its treatment is a challenge that is caused by the growing resistance of pathogenic fungi to drugs used. Therapeutic interventions for recurrent vulvovaginal candidiasis should take into account the normalization of the general condition and use of effective antimycotic drugs with adequate duration of therapy. The article describes the experience of the antimycotic drug Fluzamed in treatment of vulvovaginal candidiasis with its recurrent course. We can recommend Fluzamed in recurrent vulvovaginal candidiasis, given the rapid achievement of therapeutic effects, good tolerance, absence of adverse reactions, affordability and ease use.
Key words: candidiasis, treatment, fluconazole, Fluzamed.